Philosophy of Care
My philosophy of care is to give every patient an exceptional care experience at a level that I would provide for my own family. I enjoy listening to my patients' personal lives and view each one as an individual with unique concerns and needs. My goal is to always provide the highest level of compassionate and skillful care for my patients.
Dr. Rogers is board certified in interventional cardiology and vascular medicine, and is an integral member of the cardiovascular clinical and research program. He serves as the Director of Interventional Cardiology and is the Program Director for the Interventional Cardiology Fellowship.
Dr. Rogers has been widely published and has served as invited faculty at national and international meetings. His current clinical focus is the treatment of adult structural heart disease using minimally invasive transcatheter methods, such as MitraClip therapy for mitral regurgitation and transcatheter left atrial appendage occlusion.
Dr. Rogers serves as the Medical Director of the Cardiovascular Medicine Clinical Research Unit. Research is directed at the treatment if adult structural heart disease with an emphasis on the management of valvular heart disease using emerging minimally invasive and percutaneous procedures.
Director, Interventional Cardiology
Program Director, Cardiovascular Interventional Fellowship
Medical Director, Cardiovascular Research Unit
Physician Referrals: 916-734-5678
M.A., Clinical Research K30 MCRTP Program, UC Davis School of Medicine, Sacramento CA 2007
A.B., Harvard University, Cambridge MA 1991
Interventional Cardiology, Barnes-Jewish Hospital, St. Louis MO 2002-2003
American Board of Internal Medicine, Cardiovascular Medicine, 2002
American Board of Internal Medicine, Interventional Cardiology, 2003
American Board of Vascular Medicine, 2005
American College of Cardiology
American Heart Association
SCAI Structural Heart Disease Council
Society for Cardiac Angiography and Interventions
Select Honors and Awards:
Interventional Procedures for Adult Structural Heart Disease Textbook: Highly Commended in the Cardiology category of the 2014 British Medical Association (BMA) Medical Book Awards, 2014
Young Investigator Best Abstract for Mitral Valve Technologies Research, New Interventions in Transcatheter Valve Techniques Symposium, 2006
First place, Sixth Annual AstraZeneca Cardiovascular Young Investigators' Forum, 2000
Knowlton Incentive for Excellence Award, Barnes-Jewish Hospital, 1998
American College of Physicians' William M. Fogarty Jr. Book Award, 1995
Harvard National Scholar, 1991
Select Recent Publications:
Singh GD, Smith TW, Boyd WD, Southard JA, Wong GB, Philip F, Low RI, Rogers JH. Complete Transcatheter Treatment of Degenerated Bioprosthetic Mitral Regurgitation: Transapical Paravalvular Leak Closure Followed by Transseptal Mitral Valve-in-Valve Replacement. JACC Cardiovasc Interv. 2015 Dec 21;8(14):e229-31
Rogers JH, Thomas M, Morice MC, Narbute I, Zabunova M, Hovasse T, Poupineau M, Rudzitis A, Kamzola G, Zvaigzne L, Greene S, Erglis A. Treatment of Heart Failure With Associated Functional Mitral Regurgitation Using the ARTO System: Initial Results of the First-in-Human MAVERIC Trial (Mitral Valve Repair Clinical Trial). JACC Cardiovasc Interv. 2015 Jul;8(8):1095-104.
Singh GD, Smith TW, Rogers JH. Multi-MitraClip therapy for severe degenerative mitral regurgitation: "anchor" technique for extremely flail segments. Catheter Cardiovasc Interv. 2015 Aug;86(2):339-46.
Kuhn BT, Javed U, Armstrong EJ, Singh GD, Smith TW, Whitcomb CJ, Allen RP, Rogers JH. Balloon dilation atrial septostomy for advanced pulmonary hypertension in patients on prostanoid therapy. Catheter Cardiovasc Interv. 2015 May;85(6):1066-72.
Rogers JH, Bolling SF. Approaches to the management of functional tricuspid regurgitation. J Comp Eff Res. 2015 Nov;4(6):665-76.